General Information |
|
| NSE Symbol* | LALPATHLAB |
| Name of the Company* | Dr. Lal Path Labs Ltd. |
| ISIN* | INE600L01024 |
| Type of Meeting |
1) Board Meeting |
| Details of Committee Meeting or Other Type of Meeting | |
| Type of Intimation* | New |
| Reason for Re-schedule (postpone or prepone) / Cancellation | |
| Proposed Meeting Date | 2025-01-30 |
| Original Meeting Date | |
| Whether trading window is closed* | Yes |
| Trading Window Closure- Start date | 2025-01-01 |
| Details of Trading Window Closure End date | 2025-02-01 |
| Short Notice | |
| Date of Report* | 2025-01-23 |
Agenda Details |
|
| Agenda* |
1) Financial results 2) Dividend 3) Other business |
| Whether results are audited or unaudited | Unaudited |
| Nature of report standalone or consolidated | Standalone And Consolidated |
| Period end Type | Quarterly |
| Period up to (Month) | December |
| Period up to (Year) | 2024 |
| Mode of raising Funds | |
| Type of Dividend |
1) Interim |
| Remarks (website dissemination) | The meeting of the Board of Directors is scheduled to be held on Thursday, January 30, 2025 to inter-alia consider and approve the Un-audited (Standalone & Consolidated) Financial Results of the Company for the quarter and nine months ended December 31, 2024 and to consider the proposal of declaration of 3rd Interim Dividend, if any, on the Equity Shares of the Company for the Financial Year 2024-25 |